RE: MC73 "The document I'm most interested in is a 10Q with revenues:
Very true statement. We need to see growing revenue on 2 or 3 10-Q reports before we can understand the reorder rate. We need to know how fast a doctor's office can use up 300 tests and order more.
While I do have a "controlled excitement" for 2024 and beyond it at least seems that AXIMs business model is coming on-line. Will AXIM have a valid business over the long-term? That remains to be seen, but as long as the science team can continue to add meaningful tests, I like our chances.
We need a low cost manufacturer. We need a smart and energetic sales team. We need a smart and productive and innovative science team. We need enough products to sell that are needed by the marketplace.
I think the AXIM business model has all of these.
Not investment advice. Don't invest with money needed for food or rent. Have a good day.